Hyperglycemic pseudohypoxia and diabetic complications

Diabetes

Volumn 42, Issue 6, 1993, Pages 801-813

  Williamson, Joseph R ^a   Chang, Katherine ^a   Frangos, Myrto ^a   Hasan, Khalid S ^a   Ido, Yasuo ^a   Kawamura, Takahiko ^a   Nyengaard, Jens R ^a   Van Den Enden, Maria ^a   Kilo, Charles ^a   Tilton, Ronald G ^a  

^a Box 8118 ^*

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; FATTY ACID; GALACTOSE; GLUCOSE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITRIC OXIDE; OXYGEN RADICAL; PROSTAGLANDIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SORBITOL; SUPEROXIDE;

BLOOD VESSEL INJURY; DIABETES MELLITUS; FATTY ACID OXIDATION; GLUCOSE UTILIZATION; GLYCOLYSIS; HEART MUSCLE ISCHEMIA; HEXOSE MONOPHOSPHATE SHUNT; HUMAN; HYPERGLYCEMIA; HYPOXEMIA; METABOLIC INHIBITION; NERVE CELL LESION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; VASODILATATION;

ANIMAL; ANOXIA; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027318772     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.42.6.801     Document Type: Review

References (143)

1. 1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Diabetes 38:832-38, 1989
2. Cameron NE, Cotter MA, Low PA: Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261:E1-E8, 1991
3. Shiba T, Bursell SE, Clermont A, Sportsman R, Heath W, King GL: Protein kinase C (PKC) activation is a causal factor for the alteration of retinal blood flow in diabetes of short duration (Abstract). Invest Ophthalmol Visual Sci 32:785, 1991
4. 2 clearance measurement of blood flow: a review of technique and polarographic principles. Stroke 11:552-64, 1980
5. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T: Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44:103-50, 1992
6. Weidmann P, Beretta-Piccoli C, Trost BN: Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 7 (Suppl. 2):33-42, 1985
7. 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil. Invest Ophthalmol Visual Sci 29:861-68, 1988
8. 3H-Desmethylimiprimine) microspheres (Abstract). Invest Ophthalmol Visual Sci 33:1048, 1992
9. Sutera SP, Chang K, Marvel J, Williamson JR: Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil. Am J Physiol 263:H945-50, 1992
10. Patel V, Rassam S, Newsom R, Wiek J, Kohner E: Retinal blood flow in diabetic retinopathy. Br Med J 305:678-83, 1992
11. Ernest JT, Goldstick TK: Response of choroidal vascular resistance to hyperglycemia. Int Ophthalmol 6:119-24, 1983
12. Cunha-Vaz JG, Fonseca JR, deAbreu JRF, Lima JJP: Studies on retinal blood flow. II. Diabetic retinopathy. Arch Ophthalmol 96: 809-11, 1978
13. Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR: Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 38:1258-70, 1989
14. +. Kidney Int 41:778-88, 1992
15. Sandeman DD, Shore AC, Tooke JE: Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 327:760-64, 1992
16. Houben AJHM, Schaper NC, Nieuwenhuijzen Kruseman AC: Acute effects of local hyperglycaemia on peripheral blood flow in man. Diabetic Med 10:39-43, 1993
17. Hasan KS, Chang K, Allison W, Faller A, Santiago JV, Tilton RG, Williamson JR: Glucose-induced increases in regional blood flow are prevented by aminoguanidine and L-NMMA, inhibitors of nitric oxide synthase. (Abstract) FASEB J 7(Part I):A105, 1993
18. Hasan KS, Chang K, Allison W, Faller A, Santiago JV, Tilton RG, Williamson JR: Glucose-induced increases in ocular blood flow are prevented by aminoguanidine and L-NMMA, inhibitors of nitric oxide synthase (Abstract). Invest Ophthalmol Visual Sci 34:1127, 1993
19. Needleman P, Key SL, Isakson PC, Kulkarni PS: Relationship between oxygen tension, coronary vasodilation and prostaglandin biosynthesis in the isolated rabbit heart. Prostaglandins 9:123-34, 1975
20. Fallon TJ, Maxwell D, Kohner EM: Retinal vascular autoregulation in conditions of hyperoxia and hypoxia using the blue field entoptic phenomenon. Ophthalmology 92:701-705, 1985
21. Kostic MM, Schrader J: Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 70:208-12, 1992
22. Park KH, Rubin LE, Gross SS, Levi R: Nitric oxide is a mediator of hypoxic coronary vasodilatation: relation to adenosine and cyclooxygenase-derived metabolites. Circ Res 71:992-1001, 1992
23. Williamson DH, Lund P, Krebs HA: The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103:514-27, 1967
24. Travis SF, Morrison AD, Clements RS Jr, Winegrad AI, Oski FA: Metabolic alterations in the human erythrocyte produced by increases in glucose concentration: the role of the polyol pathway. J. Clin Invest 50:2104-12, 1971
25. Ruderman NB, Schmahl FW, Goodman MN: Regulation of alanine formation and release in rat muscle in vivo: effect of starvation and diabetes. Am J Physiol 233:E109-14, 1977
26. Pugliese G, Tilton RG, Williamson JR: Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 7:35-59, 1991
27. Williamson JR, Kilo C, Tilton RG: Mechanisms of glucose- and diabetes-induced vascular dysfunction. In Hyperglycemia, Diabetes, and Vascular Disease. Ruderman NB, Williamson JR, Brownlee M, Eds. New York, Oxford Univ. Press, 1992, p. 107-32
28. Van den Enden M, Ostrow E, Williamson JR: The role of "hyperglycemic (metabolic) hypoxia" in the pathogenesis of diabetic complications (Abstract). Diabetologia 35 (Suppl. 1):A46, 1992
29. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-12, 1991
30. Freeman BA, Crapo JD: Biology of disease: free radicals and tissue injury. Lab Invest 47:412-26, 1982
31. Corr PB, Gross RW, Sobel BE. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res 55:135-54, 1984
32. Tahiliani AG, McNeill JH: Diabetes-induced abnormalities in the myocardium. Life Sci 38:959-74, 1986
33. Dvornik D: Aldose Reductase Inhibition: An Approach to the Prevention of Diabetic Complications. Porte D, Ed. New York, McGraw-Hill, 1987
34. Winegrad AI: Does a common mechanism induce the diverse complications of diabetes? Diabetes 36:396-406, 1987
35. Crepaldi G, Nosadini R: Diabetic cardiopathy: Is it a real entity? Diabetes Metab Rev 4:273-88, 1988
36. Kinoshita JH, Nishimura C: The involvement of aldose reductase in diabetic complications. Diabetes Metab Rev 4:323-37, 1988
37. Brownlee M, Cerami A, Vlassara H: Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 4:437-51, 1988
38. Ruderman NB, Williamson JR, Brownlee M: Glucose and diabetic vascular disease. FASEB J 6:2905-14, 1992
39. Ruderman NB, Williamson JR, Brownlee M: Hyperglycemia, Diabetes, and Vascular Disease. New York, Oxford Univ. Press, 1992
40. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA: Complications: neuropathy, pathogenetic considerations. Diabetes Care 15:1902-25, 1992
41. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG: Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119-25, 1993
42. Tilton RG, Chang K, Hasan KS, Smith S, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end product formation. Diabetes 42:221-32, 1993
43. Cameron NE, Cotter MA, Robertson S: Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition. Diabetologia 32:365-70, 1989
44. Cameron NE, Cotter MA, Robertson S: Changes in skeletal muscle contractile properties in streptozocin-induced diabetic rats and role of polyol pathway and hypoinsulinemia. Diabetes 39:460-65, 1990
45. Ao S, Shingu Y, Kikuchi C, Takano Y, Nomura K, Fujiwara T, Ohkubo Y, Notsu Y, Yamaguchi I: Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat. Metabolism 40:77-87, 1991
46. Cameron NE, Cotter MA: Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35:1011-19, 1992
47. Cameron NE, Cotter MA: Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats. Br J Pharmacol 107:939-44, 1992
48. Cohen RA, Tesfamariam B: Diabetes mellitus and the vascular endothelium. In Hyperglycemia, Diabetes, and Vascular Disease Ruderman NB, Williamson JR, Brownlee M, Eds. New York, Oxford Univ. Press, 1992, p. 48-58
49. Feuvray D, Idell-Wenger JA, Neely JR: Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res 44:322-29, 1979
50. Tilton R, Daugherty A, Sutera SP, Larson KB, Land MP, Rateri DL, Kilo C, Williamson JR: Myocyte contracture, vascular resistance, and vascular permeability after global ischemia in isolated hearts from alloxan-induced diabetic rabbits. Diabetes 38:1484-91, 1989
51. 2+ metabolism. Circ Res 62:931-40, 1988
52. 2+-binding activities due to oxygen free radicals. Basic Res Cardiol 85:45-54, 1990
53. Low PA: Recent advances in the pathogenesis of diabetic neuropathy. Muscle Nerve 10:121-28, 1987
54. + content on the pathways of carbohydrate metabolism and lipogenesis in rat liver. Eur J Biochem 15:179-90, 1970
55. Cheng HM, González RG: The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. Metabolism 35 (Suppl. 1):10-14, 1986
56. Griffin BW, McNatt LG, York BM Jr: Characterization of aldose reductase activities from human and animal sources by a sensitive fluorescence assay. In Enzymology and Molecular Biology and Carbonyl Metabolism Weiner H, Ed. New York, Liss, 1987, p. 325-40
57. Rose IA, Warms JVB: Control of glycolysis in the human red blood cell. J Biol Chem 241:4848-54, 1966
58. Kobayashi K, Neely JR: Control of maximum rates of glycolysis in rat cardiac muscle. Circ Res 44:166-75, 1979
59. Frangos M, Smith S, Santiago J, Kilo C: Sorbitol-induced imbalances in glycolysis in human erythrocytes are reduced by pyruvate (Abstract). Diabetes 39 (Suppl. 1):274A, 1990
60. Williamson JR, Chang K, Allison W, Burgan J, Tilton RG: Inhibition of retinal vascular dysfunction in diabetic rats by S-0773, an inhibitor of sorbitol dehydrogenase (Abstract). Invest Ophthalmol Visual Sci 34:712, 1993
61. Williamson JR, Chang K, Allison W, Smith SR, Burgan J, Tilton RG: Sorbitol dehydrogenase inhibition (SDI) attenuates sciatic nerve vascular dysfunction in diabetic rats (Abstract). Diabetes. In press
62. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J: Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31-38, 1990
63. Hasan KS, Santiago JV, Williamson JR: Acute hyperglycemia-induced increases in regional blood flow are prevented by pyruvate and by tolrestat (Abstract). Diabetes. In press
64. Williamson JR, Chang K, Ostrow E, Allison W, Harlow J, Kilo C: Sorbitol-induced increases in vascular albumin clearance (VAC) are prevented by pyruvate but not myo-inositol (Abstract). Diabetes 38:94A, 1989
65. + by an aldose reductase inhibitor and pyruvate (Abstract). Invest Ophthalmol Visual Sci 34:716, 1993
66. Trevisan R, Nosadini R, Fioretto P, Velussi M, Avogaro A, Duner E, Iori E, Doria A, Merkel C, Valerio A, Crepaldi G: Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects: Effects of acetoacetic, lactic, and acetic acids. Diabetes 36:1073-81, 1987
67. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 83:1667-75, 1989
68. Lee T-S, Saltsman KA, Ohashi H, King GL: Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86:5141-45, 1989
69. Craven PA, Davidson CM, DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667-74, 1990
70. +-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or callphostin C, inhibitors of protein kinase C. Diabetes 42:257-62,1993
71. King GL, Shiba T, Feener EP, Nayak R: Cell culture model for the study of vascular complications of diabetes: the effect of high glucose levels on metabolism and growth of vascular cells. In Hyperglycemia, Diabetes, and Vascular Disease Ruderman NB, Williamson JR, Brownlee M, Eds. New York, Oxford Univ. Press, 1992, p. 162-77
72. Zhu X, Eichberg J: 1,2-diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J Neurochem 55:1087-90, 1990
73. Okumura K, Nishiura T, Awaji Y, Kondo J, Hashimoto H, Ito T: 1,2-diacylglycerol content and its fatty acid composition in thoracic aorta of diabetic rats Diabetes 40:820-24, 1991
74. Williams B, Schrier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41:1464-72, 1992
75. Drummond AH, Raeburn CA: The interaction of lithium with thyrotropin-releasing hormone-stimulated lipid metabolism in GH3 pituitary tumour cells. Biochem J 224:129-36, 1984
76. Downes CP, Stone MA: Lithium-induced reduction in intracellular inositol supply in cholinergically stimulated parotid gland. Biochem J 234:199-204, 1986
77. Berridge MJ, Downes CP, Hanley MJ: Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:411-19, 1989
78. Godfrey PP: Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol. Biochem J 258:621-24, 1989
79. Williamson JR, Kreisberg RA, Felts PW: Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56:247-54, 1966
80. Neely JR, Whitmer KM, Mochizuki S: Effects of mechanical activity and hormones on myocardial glucose and fatty acid utilization. Circ Res 38 (Suppl. 1):22-30, 1976
81. Knabb MT, Saffitz JE, Corr PB, Sobel BE: The dependence of electro-physiological derangements on accumulation of endogenous long-chain acyl carnitine in hypoxic neonatal rat myocytes. Circ Res 58:230-40, 1986
82. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE: Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 83:927-36, 1989
83. Williamson JR, Chang K, Kilo C, Sherman WR, Montenero M, Arrigoni-Martelli E: Prevention of glucose-induced vascular functional changes by acetyl-L-carnitine. Diabetologia 33 (Suppl.): A175, 1990
84. Lowitt S, Malone JI, Salem A, Korthals J: Acetylcarnitine improves neuronal function in streptozotocin (STZ) diabetic rats (Abstract). Diabetes 39 (Suppl. 1):155A, 1990
85. 131I-BSA clearance. Invest Ophthalmol Visual Sci 32:1029, 1991
86. Vary TC, Neely JR: A mechanism for reduced myocardial carnitine levels in diabetic animals. Am J Physiol 243:H154-58, 1982
87. Ido Y, Rattarasarn M, Allison W, Orfalian Z, Arrigoni-Martelli E: Effects of acetyl-L-carnitine (AC) on functional and metabolic abnormalities in diabetic peripheral nerve (Abstract). Diabetes. In press
88. Farber HW, Center DM, Rounds S: Effect of ambient oxygen on cultured endothelial cells from different vascular beds. Am J Physiol 253:H878-83, 1987
89. Farber HW, Barnett HF: Differences in prostaglandin metabolism in cultured aortic and pulmonary arterial endothelial cells exposed to acute and chronic hypoxia. Circ Res 68:1446-57, 1991
90. Martin LD, Barnes SD, Wetzel RC: Acute hypoxia alters eicosanoid production of perfused pulmonary artery endothelial cells in culture. Prostaglandins 43:371-82, 1992
91. Craven PA, Caines MA, DeRubertis FR: Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes. Metabolism 36:95-103, 1987
92. Craven PA, DeRubertis FR: Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat. Metabolism 38:649-54, 1989
93. Chang WP, Dimitriadis E, Allen T, Dunlop ME, Cooper M, Larkins RG: The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia 34:225-31, 1991
94. 2. Am J Physiol 257:H1327-33, 1989
95. Tesfamariam B, Brown ML, Deykin D, Cohen RA: Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85:929-32, 1990
96. Craven PA, Patterson MC, DeRubertis FR: Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37:429-35, 1988
97. Halliwell B: Superoxide, iron, vascular endothelium and reperfusion injury. Free Radical Res Comms 5:315-18, 1989
98. Lefer AM, Tsao PS, Lefer DJ, Ma X: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 5:2029-34, 1991
99. Ratych RE, Chuknyiska RS, Bulkley GB: The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 102:122-31, 1987
100. Block ER, Patel JM, Edwards D: Mechanism of hypoxic injury to pulmonary artery endothelial cell plasma membranes. Am J Physiol 257:0223-31, 1989
101. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-64, 1992
102. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902, 1992
103. Kukreja RC, Kontos HA, Hess ML, Ellis EF: PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH. Circ Res 59:612-19, 1986
104. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-26, 1992
105. Cameron NE, Cotter MA, Maxfield E: Antioxidant treatment prevents peripheral nerve dysfunction in diabetic rats (Abstract). Diabetologia (Suppl. 1) 35:A150, 1992
106. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-56, 1992
107. 125I-albumin permeation: roles of nitric oxide and superoxide. (Abstract). FASEB J 7:(Part II):A905, 1993
108. Tilton RG, Chang K, Faller AM: Probucol prevents vascular protein leakage induced by diabetes, glucose, and glycated proteins (Abstract). Diabetes. In press
109. Hu R-M, Levin ER, Pedram A, Frank HJL: Insulin stimulates the production and secretion of endothelin from bovine endothelial cells. Diabetes 42:351-58, 1993
110. De La Rubia G, Oliver FJ, Inoguchi T, King GL: Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes. Diabetes 41:1533-39, 1992
111. Awazu M, Parker RE, Harvie BR, Ichikawa I, Kon V: Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol 17 (Suppl. 7): S500-S502, 1991
112. Egan RW, Paxton J, Kuehl FA Jr: Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem 251: 7329-35, 1976
113. Warso MA, Lands WEM: Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull 39:277-80, 1983
114. Kanner J, Harel S, Granit R: Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27:46-49, 1992
115. Capdevila JH, Falck JR, Estabrook RW: Cytochrome P450 and the arachidonate cascade. FASEB J 6:731-36, 1992
116. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG: Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 263:539-45, 1989
117. Masumoto N, Tasaka K, Miyake A, Tanizawa O: Superoxide anion increases intracellular free calcium in human myometrial cells. J Biol Chem 265:22533-36, 1990
118. Ikebuchi Y, Masumoto N, Tasaka K, Koike K, Kasahara K: Superoxide anion increases intracellular pH, intracellular free calcium, and arachidonate release in human amnion cells. J Biol Chem 266:13233-37, 1991
119. Nakane M, Mitchell J, Forstermann W, Murad F: Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase. Biochem Biophys Res Commun 180: 1396-1402, 1991
120. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature (Lond) 351:714-18, 1991
121. Pieper GM, Gross GJ: Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 255:H825-33, 1988
122. Calver A, Collier J, Vallance P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-54, 1992
123. Elliott TG, Cockcroft JR, Groop PH, Earle K, Morocutti A, Viberti GC, Ritter JM: Vascular responses in the forearm of microalbuminuric type I (insulin-dependent) diabetic patients: evidence of altered nitric oxide biosynthesis (Abstract). Diabetologia 35 (Suppl. 1):A19, 1992
124. Smits P, Kapma J, Jacobs M, Lutterman J, Thien T: Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes 42:148-53, 1993
125. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281:627-30, 1992
126. + AT-Pase activity in rabbit aorta by hyperglycemia: possible role of endothelium-derived nitric oxide. J Clin Invest 90:727-32, 1992
127. Simon BC, Cohen RA: EDTA influences reactivity of isolated aorta from hypercholesterolemic rabbits. Am J Physiol 262:H1606-10, 1992
128. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-38, 1991
129. Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA: Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts: 1 role for lipid peroxidation? J Biol Chem 264:16957-62, 1989
130. Cagliero E, Roth T, Roy S, Maiello M, Lorenzi M: Expression of genes related to the extracellular matrix in human endothelial cells: differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. J Biol Chem 266:14244-250, 1991
131. Kreisberg JI: Biology of disease: hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells. Lab Invest 67:416-26, 1992
132. Lawson DL, Mehta JL, Nichols WW, Mehta P, Donnelly WH: Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings. J Lab Clin Med 115:541-48, 1990
133. Brüne B, Schmidt K-U, Ullrich V: Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 192:683-88, 1990
134. Frangos M, Santiago JV, Williamson JR: In human erythrocytes galactose induces greater imbalances in glycolysis than glucose (Abstract). Diabetes 40 (Suppl. 1):254A, 1991
135. Lou MF, Dickerson JE Jr, Garadi R, York BM Jr: Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res 46:517-30, 1988
136. Mak IT, Boehme P, Weglicki WB: Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells: correlation of protection with preservation of glutathione levels. Circ Res 70:1099-1103, 1992
137. Huby R, Harding JJ: Non-enzymatic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione. Exp Eye Res 47:53-59, 1988
138. Nagaraj RH, Monnier VM: Non-tryptophan fluorescence and high molecular weight protein formation in lens crystalline of rats with chronic galactosemia: prevention by the aldose reductase inhibitor sorbinil. Exp Eye Res 51:411-18, 1990
139. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH: Carbon monoxide: a putative neural messenger. Science 259:381-84, 1993
140. McCulloch DK, Campbell IW, Prescott RJ, Clarke BF: Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men. Diabetes Care 3:245-47, 1980
141. Gillery P, Monboisse JC, Maquart FX, Borel JP: Glycation of proteins as a source of superoxide. Diabete Metab 14:25-30, 1988
142. Jiang ZY, Woollard ACS, Wolff SP: Hydrogen peroxide production during experimental protein glycation. FEBS Lett 268:69-71, 1990
143. Mullarkey CJ, Edelstein D, Brownlee M: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173:932-939, 1990